This Program proposes to continue its interactive efforts aimed at elucidating the central molecular mechanisms which underlie the transformation of cultured cells and the development of a broad array of malignant tumors by the papova/papilloma families of DNA tumor viruses. During the past grant period, progress was made in understanding certain key events in the biochemical function of SV40 and PY large T Ag, PY mT and st Ags, as well as BPV and HPV E6. Among the most surprising discoveries made in this program was that the N-terminal SV40 and PY T Ag common region(s) are DNA J domains which support both the replicative and elements of the transforming properties of these viruses. Moreover, fresh insights into the degree of complexity of PY tumorigenesis emerged from studies of the behavior of PY mT mutants defective in the binding of selected signaling proteins. In the next grant period, we propose to continue to work across a wide spectrum of complementary approaches, Our goal is to take advantage of extraordinary, new opportunities for drawing a more detailed and comprehensive picture of the major biochemical links connecting T, mT, St, and E6 biochemical function to key cellular perturbations that result in the evolution of a fully transformed and tumorigenic phenotype. The overriding goal of this work is to define the relationships between papovaviral transforming mechanisms and those processes which -give rise to spontaneous human neoplasms.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA050661-15
Application #
6633022
Study Section
Subcommittee G - Education (NCI)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1989-07-01
Project End
2004-02-29
Budget Start
2003-05-06
Budget End
2004-02-29
Support Year
15
Fiscal Year
2003
Total Cost
$2,201,979
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Becker, Jürgen C; Stang, Andreas; Hausen, Axel Zur et al. (2018) Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother 67:341-351
Becker, Jürgen C; Stang, Andreas; DeCaprio, James A et al. (2017) Merkel cell carcinoma. Nat Rev Dis Primers 3:17077
Denis, Deborah; Rouleau, Cecile; Schaffhausen, Brian S (2017) A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling. J Virol 91:
Starrett, Gabriel J; Marcelus, Christina; Cantalupo, Paul G et al. (2017) Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma. MBio 8:
Cizmecioglu, Onur; Ni, Jing; Xie, Shaozhen et al. (2016) Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. Elife 5:
Rouleau, Cecile; Pores Fernando, Arun T; Hwang, Justin H et al. (2016) Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP. J Virol 90:7032-7045
Berrios, Christian; Jung, Joonil; Primi, Blake et al. (2015) Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors. J Virol 89:857-62
Luo, Leo Y; Kim, Eejung; Cheung, Hiu Wing et al. (2015) The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Mol Cancer Res 13:502-9
Hettmer, Simone; Schinzel, Anna C; Tchessalova, Daria et al. (2015) Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. Elife 4:
White, Elizabeth A; Kramer, Rebecca E; Hwang, Justin H et al. (2015) Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens. J Virol 89:2857-65

Showing the most recent 10 out of 147 publications